Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acerus Pharmaceuticals Corporation
Acerus Pharmaceuticals Corporation
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Natesto
Testosterone
2014-05-28
2024-2039
Breast neoplasms
,
Hypogonadism
,
Delayed puberty
,
Psychological sexual dysfunctions
,
Prostatic neoplasms
,
Menorrhagia
,
Primary ovarian insufficiency
,
Hot flashes
,
Premature menopause
Noctiva
Desmopressin
2017-03-03
2024-2030
Hemorrhage
,
Thrombocytopenia
,
Von willebrand diseases
,
Neurogenic diabetes insipidus
,
Enuresis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Testosterone
hypogonadism
,
menopause
,
cardiovascular diseases
Testosterone undecanoate
hypogonadism
,
cardiovascular diseases
Testosterone enanthate
hypogonadism
,
cardiovascular diseases
Doconexent
neoplasms
,
breast neoplasms
,
multiple myeloma
,
recurrence
,
b-cell chronic lymphocytic leukemia
,
non-hodgkin lymphoma
,
contraception
,
headache
,
pelvic pain
,
libido
Follitropin
fertility
,
insemination
,
female infertility
,
anovulation
,
infertility
,
polycystic ovary syndrome
,
syndrome
Endocrine
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
hypertriglyceridemia
,
fatty liver
Sustanon
hypogonadism
Histone-arginine methyltransferase carm1
pain
,
diabetic neuropathies
Surlorian
pain
,
diabetic neuropathies
Demand
neoplasm metastasis
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
retinal vein occlusion
,
diabetes mellitus
,
hemophilia a
,
erectile dysfunction
,
hematologic diseases
,
hemostatic disorders
,
blood coagulation disorders
,
fatigue
,
healthy volunteers/patients
,
metabolism
,
breast neoplasms
,
circulating neoplastic cells
Isoxaflutole
diabetes mellitus
,
healthy volunteers/patients
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
postmenopause
,
cardiovascular diseases
,
metabolic diseases
,
obstructive sleep apnea
,
non-alcoholic fatty liver disease
,
metabolic syndrome
,
overweight
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use